400客服电话
购买数据产品
400-9696-311 转1
定制咨询业务
400-9696-311 转2
数据与AI定制业务
400-9696-311 转3
商务合作及其他问题
400-9696-311 转4
投诉及建议
400-9696-311 转5
ChiCTR1900021694
尚未开始
/
/
/
2019-03-05
/
/
Patients receiving first chemotherapy
Effects of immersive virtual reality for preventing and managing anxiety, nausea and vomiting among paediatric cancer patients receiving their first chemotherapy: An exploratory trial
Effects of immersive virtual reality for preventing and managing anxiety, nausea and vomiting among paediatric cancer patients receiving their first chemotherapy: An exploratory trial
The objectives of this trial are: 1. To assess the parameters and feasibility for the design of a definitive trial,- Screening, eligibility, consent and withdrawal rates; 2. To assess the data collection procedure and collection of preliminary data, - Anxiety (self-reported and physiological responses including heart rate and mean arterial blood pressure), anticipatory and acute CINV between the intervention and control groups; 3. To assess the satisfaction of the chemotherapy procedure to parents and nurses; 4. To explore ways of improvement for the implementation of intervention and the acceptability of the intervention to patients, parents and nurses.
随机平行对照
其它
A computer-based stratified randomization is used to randomly assign patients into one group or the other. Strata are constructed on the basis of cancer types. Randomization will be conducted by an independent statistician.
The nature of an IVR intervention may be impractical for the blinding of participants and outcome assessors.
Nil
/
10
/
2019-07-01
2020-06-30
/
Patients who are (1) aged between 6 and 12 years; (2) chemotherapy naive; (3) scheduled to receive their first intravenous chemotherapy; (4) can understand Chinese.；
请登录查看Patients who have (1) identified cognitive and learning problems in their medical record; (2) brain tumours or metastasis; (3) identified contact precautions; (4) previous history of seizures or motion sickness.；
请登录查看香港中文大學那打素護理學院
/
求实药社2026-07-16
医药观澜2026-07-16
BioArt2026-07-16
一度医药2026-07-16
医药笔记2026-07-16
医药笔记2026-07-16
杏泽资本2026-07-16
药明康德2026-07-16
中国北京同仁堂官微2026-07-15
400-9696-311 转1
400-9696-311 转3
400-9696-311 转4
400-9696-311 转5
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
